Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Diabetes Publish Ahead of Print published online ahead of print October 31, 2007
DOI: 10.2337/db07-0704

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
db07-0704v1
57/2/288    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ayala, J. E.
Right arrow Articles by Drucker, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ayala, J. E.
Right arrow Articles by Drucker, D. J.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

Insulin Action in the Double Incretin Receptor Knockout Mouse

Julio E. Ayala1, Deanna P. Bracy1, Tanya Hansotia2, Grace Flock2, Yutaka Seino3, David H. Wasserman1, and Daniel J. Drucker2

1Department of Molecular Physiology & Biophysics and NIH Mouse Metabolic Phenotyping Center, Vanderbilt University School of Medicine, Nashville, TN 37232, USA
2Banting and Best Diabetes Centre, Departments of Medicine and Laboratory Medicine and Pathobiology, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada
3Kansai Electric Power Hospital, Osaka, Japan

Objective: The incretins GLP-1 and GIP have been postulated to play a role in regulating insulin action although the mechanisms behind this relationship remain obscure. We used the hyperinsulinemic-euglycemic clamp to determine sites where insulin action may be modulated in double incretin receptor knockout (DIRKO) mice, which lack endogenous incretin action.

Research Design and Methods: DIRKO and wild-type (WT) mice were fed regular chow or high fat (HF) diet for 4 months. Clamps were performed on 5h-fasted, conscious, unrestrained mice using an arterial catheter for sampling.

Results: Compared to WT mice, chow and HF-fed DIRKO mice exhibited decreased fat and muscle mass associated with increased energy expenditure and ambulatory activity. Clamp rates of glucose infusion (GIR), production (endoRa), and disappearance (Rd) were not different in chow-fed WT and DIRKO mice, although insulin levels were lower in DIRKO mice. Liver Akt expression was decreased, but Akt activation was increased, in chow-fed DIRKO compared to WT mice. HF feeding resulted in fasting hyperinsulinemia and hyperglycemia in WT but not in DIRKO mice. GIR, suppression of endoRa, and stimulation of Rd were inhibited in HF-fed WT but not in DIRKO mice. HF feeding resulted in impaired tissue glucose uptake (Rg) in skeletal muscle of WT but not of DIRKO mice. Liver and muscle Akt activation was enhanced in HF-fed DIRKO compared to WT mice.

Conclusions: In summary, DIRKO mice exhibit enhanced insulin action compared to WT mice when fed a regular chow diet and are protected from HF diet-induced obesity and insulin resistance.


Correspondence: julio.ayala{at}vanderbilt.edu


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.